Calici’s research team is proud to announce the publication of our second co-authored paper.This study centers on blood glucose regulation through activation of the insulin signaling pathway, presenting significant…

We are proud to announce that the first customer-led publication utilizing Pharmaco-Net, Calici’s protein structure-based AI drug discovery platform, has been published in Proceedings of the National Academy of…

CALICI and CellFree Sciences Sign Strategic Partnership to Accelerate Drug Discovery between Korea and Japan CALICI, a protein structure-based AI drug discovery (SBDD) company headquartered in the U.S. and…